Enoxaparin sodium biosimilar (PT Kalbe)
依诺肝素钠生物类似药 (PT Kalbe)
Report date: 2023/01/10 18:03:04
Base Information
Drug NameEnoxaparin sodium biosimilar (PT Kalbe)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2012/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKalbe Farma
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A